Kolexia
Gabelle Audrey
Neurologie
Hôpital Gui de Chauliac
Montpellier, France
304 Activités
958 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Démence Démence frontotemporale Plaque amyloïde Fragilité Troubles de la mémoire Maladies neurodégénératives Inflammation Maladie à corps de Lewy

Industries

Biogen
11 collaboration(s)
Dernière en 2022
Roche
6 collaboration(s)
Dernière en 2021
KPL
5 collaboration(s)
Dernière en 2021
IQVIA
2 collaboration(s)
Dernière en 2020

Dernières activités

The free plasma amyloid Aβ /Aβ ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ /Aβ ratio. The BALTAZAR study.
Neurobiology of disease   27 février 2024
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.
Genetics in medicine : official journal of the American College of Medical Genetics   24 janvier 2024
Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives.
Molecular psychiatry   16 janvier 2024
Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum.
International journal of molecular sciences   11 décembre 2023
Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association   26 octobre 2023
Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
Journal of Alzheimer's disease : JAD   19 septembre 2023
Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia.
Clinical chemistry   04 septembre 2023
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.
Journal of neurology, neurosurgery, and psychiatry   03 avril 2023
Forecasting the Prevalence of Alzheimer's Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022.
The journal of prevention of Alzheimer's disease   23 mars 2023
Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer's disease diagnosis in a memory clinic cohort.
Alzheimer's research & therapy   18 février 2023